Integrative AI-Based Study of Chronic Pain in Rheumatoid Arthritis Using Multiomic and Neurophysiological Profiling
Led by 4th Military Clinical Hospital with Polyclinic, Poland · Updated on 2026-08-18
100
Participants Needed
1
Research Sites
22 weeks
Total Duration
AI-Summary
What This Trial Is About
Rheumatoid arthritis RA is a chronic autoimmune disease where pain remains a major symptom despite advances in treatments controlling inflammation. This study investigates persistent moderate-to-severe pain in RA patients who have achieved clinical remission, exploring how chronic pain may be driven by central nervous system changes rather than ongoing inflammation. The RA-PAIN-AI study is an observational, case-control design aiming to identify pain-related clinical, neurophysiological, and multiomic signatures using artificial intelligence.
Participants include two groups of adults with RA those with active disease needing biological therapy, and those in sustained remission without significant pain. No experimental treatments are given instead, participants undergo clinical assessments, standardized questionnaires, peripheral blood collection for multiomic profiling, and optional EEG neurophysiological evaluation at baseline and 3-6 months follow-up. Biological samples are analyzed ex vivo using genomics, transcriptomics, and secretomics.
During the study, participants complete detailed questionnaires about pain, function, quality of life, psychological status, sleep, and fatigue. Blood samples and optional EEG recordings are collected twice. Researchers use AI methods to integrate clinical and biological data to classify pain subtypes and identify biomarkers predicting chronic pain persistence despite effective anti-inflammatory therapy. The study supports developing personalized treatments and extends over multiple visits with routine clinical care maintained throughout.
CONDITIONS
Brief Title
Integrative AI-Based Multiomic and Neurophysiological Profiling of Chronic Pain in Rheumatoid Arthritis
Research Team
W
Wojciech Tanski, gen. bryg. dr hab. n. med.
A
Anna Skotny, dr n. med.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
4th Military Clinical Hospital with Polyclinic, Poland
Lead Sponsor
Lukasiewicz - PORT Polish Center for Technology Development
Collaborating Sponsor
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
Age 18 years or older
Confirmed diagnosis of rheumatoid arthritis
For the study group: active disease requiring biological therapy under national drug program B.33
For the control group: sustained clinical remission for at least 1.5 years under biological therapy without chronic pain
Ability to provide written informed consent
Willingness to participate in clinical assessments, blood sampling, questionnaires, and optional EEG
You will not qualify if you...
Contraindications to biological therapy based on Polish Society of Rheumatology and National Health Fund guidelines
Inability to provide informed consent
Any condition that may interfere with participation or data interpretation as judged by the investigator
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Baseline Assessment
Duration - 1 day
Participants undergo clinical assessment, complete standardized questionnaires, provide peripheral blood samples, and may have an EEG evaluation if selected.
1 visit (in-person)
Follow-up Assessment
Duration - 1 day
Participants return 3 to 6 months later for repeat blood collection, questionnaire completion, and optional EEG assessment if performed at baseline.
1 visit (in-person)
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Bionic Breast Project Using a Neuroprosthetic Device to Restore Touch and Reduce Chronic Pain After Mastectomy
Randomized Placebo-Controlled Study of LY4065967 for Treating Chronic Low Back Pain
Randomized Trial Comparing Oral LY4065967 and Placebo for Knee Osteoarthritis Pain Treatment
Testing a Community Health Worker Program to Reduce Chronic Pain and Loneliness
in Older Adults Living in Rural Areas
Study of Chronic Post-Surgical Pain in Children Aged Up to 16 Years
Tracking Pain and Risk Factors After Common Pediatric Surgeries
Remote Group and Individual Coaching to Increase Daily Steps, Reduce Pain, and Support Weight Loss in Older Adults with Knee or Hip Osteoarthritis
Randomized Study of Cebranopadol to Reduce Opioid Withdrawal Symptoms in Adults with Chronic Pain
Phase I Open-Label Study of CLN-978, a CD19-Directed T Cell Engager, in Adults with Treatment-Refractory Rheumatoid Arthritis
Evaluating Dual-Carrier-Frequency Transcranial Alternating Current Stimulation Targeting the Hippocampus for Chronic Non-Specific Low Back Pain Treatment with Rehabilitation
Trial of Adding Buprenorphine Patch, Cognitive Behavioral Therapy, and Transcranial Magnetic Stimulation to Improve Outcomes in Adults on Long-Term Opioid Therapy for Chronic Pain
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Integrative AI-based multiomic and neurophysiological profiling of chronic pain in rheumatoid arthritis: study protocol for the prospective, observational, case-control RA-PAIN-AI study.
Anna Skotny, Kuba Ptaszkowski, Katarzyna Kościelska-Kasprzak...